Redhawk Wealth Advisors, Inc. Halozyme Therapeutics, Inc. Transaction History
Redhawk Wealth Advisors, Inc.
- $739 Million
- Q2 2025
A detailed history of Redhawk Wealth Advisors, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Redhawk Wealth Advisors, Inc. holds 37,419 shares of HALO stock, worth $2.12 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
37,419
Previous 32,592
14.81%
Holding current value
$2.12 Million
Previous $2.08 Million
6.4%
% of portfolio
0.26%
Previous 0.3%
Shares
5 transactions
Others Institutions Holding HALO
# of Institutions
594Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$997 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$726 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$342 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$220 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$208 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.88B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...